Primary Record
Cholesterol Formate
- In stock
- 3,054 g
- Purity
- 98.3 %
- CAS
- 4351-55-7
Compound Identifiers & Properties
- CAS
- 4351-55-7
- PubChem CID
- 165217
- SMILES
- C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC=O)C)C
- Canonical SMILES
- CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC=O)CC[C@]4(C)[C@H]3CC[C@]12C
Names & Synonyms
- Cholesterol Formate
- Cholesteryl formate
- Ester
- Esters
- Organic Ester
- Cholesterol=formate
- 4351-55-7
- Cholesterol hemisuccinate
- AC1L4WAR
- cholesterol ester 14:0
- cholesterol ester 14:1
- cholesterol ester 15:0
- cholesterol ester 15:1
- cholesterol ester 16:0
- cholesterol ester 17:0
- cholesterol ester 18:0
- cholesterol ester 20:0
- cholesterol ester 20:6
- cholesterol ester 22:0
- cholesterol ester 22:2
- Cholesteryl docosadienoate
- 22:2 Cholesterol ester
- RefChem:388959
- Cholest-5-en-3beta-yl formate
- 3beta-Acetoxy-cholest-5-ene
- cholesterol ester(22:2)
- Formic Acid Cholesterol Ester
- 3-Amino crotonic acid cinnamyl
- Cholest-5-en-3-yl formate
- 5-cholesten-3|A-ol formate
- MFCD00046243
- YEYCQJVCAMFWCO-PXBBAZSNSA-N
- Cholest-5-en-3beta-ol formate
- orb1744028
- SCHEMBL1045464
- SCHEMBL1354770
- 3beta-(Formyloxy)cholest-5-ene
- C28H46O2
- ChE 22:2
- 5-Cholesten-3.beta.-ol formate
- CHEBI:35701
- CTK8B1696
- EINECS 224-416-9
- DTXSID30963018
- CHEBI:183801
- CHEBI:191860
- CHEBI:191861
- CHEBI:191862
- CHEBI:191863
- CHEBI:191864
- CHEBI:191865
- CHEBI:191866
- CHEBI:191867
- CHEBI:191868
- CHEBI:191869
- Formic acid 3beta-cholesteryl ester
- ZINC5758807
- ANW-30003
- AR-1G7892
- c0671
- CID165217
- (3beta)-cholest-5-en-3-ylmethanoate
- AKOS015837667
- Methanoic acid 3beta-cholesteryl ester
- ACN-054754
- C28-H46-O2
- CE 14:0
- CE 14:1
- CE 15:0
- CE 15:1
- CE 16:0
- CE 17:0
- CE 18:0
- CE 20:0
- CE 20:6
- CE 22:0
- CE 22:2
- Cholest-5-en-3-ol (3.beta.)-, formate
- EBC-617564
- FC61968
- Cholesterol formate, 97% - 10G 10g
- Formic acid cholest-5-en-3beta-yl ester
- (3I(2))-cholest-5-en-3-yl methanoate
- CE(14:0)
- CE(14:1)
- CE(15:0)
- CE(15:1)
- CE(16:0)
- CE(17:0)
- CE(18:0)
- CE(20:0)
- CE(20:6)
- CE(22:0)
- CE(22:2)
- SY075638
- Cholest-5-en-3-yl formate, (3.beta.)-
- J205.725E
- TR-031854
- CS-0183060
- FT-0623726
- NS00046461
- 351C557
- amino-3,3a,8,8a-tetrahydro-, 1,1-dimethylethyl
- [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] formate
- I14-105445
- Indeno[1,2- c ]pyrrole-2(1 H )-carboxylic acid, 8-
- (1R,3aS,3bS,7S,9aR,9bS,11aR)-9a,11a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-yl formate
- 103909-86-0
- [(3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] formate
- 1369504-85-7
- 5428-15-9
- Y01